...
首页> 外文期刊>Gynecologic Oncology Reports >Pelvic exenteration by robotically-assisted laparoscopy: A feasibility series of 6 cases
【24h】

Pelvic exenteration by robotically-assisted laparoscopy: A feasibility series of 6 cases

机译:机器人腹腔镜下盆腔引流:6例可行性研究

获取原文
           

摘要

After concomitant chemo-radiation therapy, 20 to 30% of advanced cervical cancers recur in irradiated territory. Pelvic exenteration remains a therapeutic option for selected patients. However, this procedure remains complex because of tissue fragility after radiotherapy and their associated co-morbidities. Minimally invasive surgery such as robotically assisted laparoscopy may overcome these surgical challenges. The objective of this study was to evaluate the feasibility of pelvic exenteration with robotically assisted laparoscopy. Patients who underwent this procedure between 2015 and 2016 were included. Patients characteristics, treatment indication, intraoperative events, immediate and late complications, and histological outcomes were recorded. The data of 6 patients were analyzed. The primary cancer staging ranged from IB1 to IIB. All cases were loco-regional recurrence and 2 cases presented with with vesico-vaginal fistula. All patients had a history of pelvic irradiation. The mean operative time was 6.7?h. No complications occurred during surgery. The average hospital stay was 11.5?days. Immediate complications were mostly represented by urinary tract infections (4/5). Histological margins were clear in 67% (4/6), and a focal involvement was found in 33% (2/6) of cases. Late complications occurred within 82?days on average and included stenosis of ileal anastomosis, wound infection, acute renal failure, and pulmonary embolism. Revision surgery was necessary in 2 cases. There were 3 local recurrences occurring within an average of 215?days. In the light of these results, pelvic exenteration by robotically assisted laparoscopy may represent a valuable treatment modality of recurrent cervical cancer with low immediate postoperative morbidity. Highlights ? Robotic-assisted laparoscopy improve surgical performance in pelvic exenterations. ? Robotic-assisted laparoscopy is associated with good post-operative results. ? Robotic-assisted laparoscopy is associated with good histological results. ? This series described 6 real pelvic exenterations contrary to other smaller series.
机译:伴随化学放射治疗后,有20%至30%的晚期宫颈癌会在受辐照的地区复发。对于某些患者,盆腔引流仍然是一种治疗选择。然而,由于放疗后的组织脆弱性及其相关的合并症,该过程仍然很复杂。诸如机器人辅助腹腔镜之类的微创手术可以克服这些手术难题。这项研究的目的是评估用机器人辅助腹腔镜进行盆腔引流的可行性。纳入2015年至2016年间接受此手术的患者。记录患者的特征,治疗适应症,术中事件,即刻和晚期并发症以及组织学结果。分析了6例患者的数据。原发癌分期从IB1到IIB。所有病例均为局部复发,2例伴有阴道阴道瘘。所有患者都有骨盆照射史。平均手术时间为6.7小时。手术期间无并发症发生。平均住院天数为11.5天。立即发生的并发症主要表现为尿路感染(4/5)。组织学切缘在67%(4/6)中很明显,在33%(2/6)的病例中发现了局部受累。晚期并发症平均发生在82天之内,包括回肠吻合口狭窄,伤口感染,急性肾功能衰竭和肺栓塞。 2例需要进行翻修手术。平均215天之内发生3例局部复发。根据这些结果,通过机器人辅助腹腔镜进行的盆腔切除术可能代表了复发性宫颈癌的一种有价值的治疗方式,其术后并发症发生率低。强调 ?机器人辅助的腹腔镜检查可改善盆腔引流的手术性能。 ?机器人辅助腹腔镜检查具有良好的术后效果。 ?机器人腹腔镜检查与良好的组织学结果相关。 ?与其他较小的系列相反,该系列描述了6个实际的盆腔切除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号